EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile‐induced mesothelioma via ferroptosis resistance

Yaguang Luo, Shinya Akatsuka, Yashiro Motooka iD, Yingyi Kong, Hao Zheng, Tomoji Mashimo, Tatsuhiko Imaoka iD, Shinya Toyokuni iD

Cancer Science · 2023-04 · 114 (4) · 1423-1436

DOI: 10.1111/cas.15705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 02.02.2023. Verfasst von Yaguang Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Asbestos, Ferroptosis, Lung Neoplasms, Mesothelioma, Malignant. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Core Research for Evolutional Science and Technology, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant mesothelioma (MM) is still a social burden associated with asbestos exposure. Local iron accumulation thereby represents the major pathogenesis, followed by oxidative DNA strand breaks and genomic alterations in the mesothelium. BRCA1 is a critical component of homologous recombination repair directed to DNA double‐stranded breaks, whereas BRCA1 germline mutation is an established risk for breast/ovarian cancer, its role in MM development remains to be elucidated. Murine Brca1 mutant models so far have not reproduced human phenotypes. However, a rat Brca1 mutant model (Mut; L63X/+ ) recently reproduced them at least partially. Here we describe the differential induction of MM in Brca1 mutant rats by intraperitoneal injection of chrysotile or crocidolite. Only Mut males injected with chrysotile revealed a promotional effect on mesothelial carcinogenesis in comparison with wild‐type and/or females, with all the MMs Brca1 haploinsufficient. Array‐based comparative genomic hybridization of MMs disclosed a greater extent of chromosomal deletions in Brca1 mutants, including Cdkn2a / 2b accompanied by Tfr2 amplification, in comparison with wild‐type tumors. Mutant MMs indicated iron metabolism dysregulation, such as an increase in catalytic Fe(II) and Ki67‐index as well as a decrease in Fe(III) and ferritin expression. Simultaneously, mutant MMs revealed ferroptosis resistance by upregulation of Slc7A11 and Gpx4. At an early carcinogenic stage of 4 weeks, induced Brca1 expression in mesothelial cells was significantly suppressed in chrysotile/Mut in comparison with crocidolite/Mut, whereas significant preference to iron with a decrease in Fe(III) has been already established. In conclusion, chrysotile exposure can be a higher risk for MM in BRCA1 mutant males, considering the rat results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsbestosFerroptosisLung NeoplasmsMesothelioma, MalignantAnimalsFemaleMaleRatsAsbestos, CrocidoliteAsbestos, SerpentineBRCA1 ProteinCarcinogenesisComparative Genomic HybridizationDNAFerric CompoundsHaploinsufficiencyIron

Stichwörter der Autor:innen

BRCA1asbestosferroptosisiron metabolismmalignant mesothelioma

Substanzen

AsbestosAsbestos, CrocidoliteAsbestos, SerpentineBRCA1 ProteinDNAFerric CompoundsIron

Autor:innen und Institutionen

  • Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Division of Animal Genetics, Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Division of Genome Engineering, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Radiation Effects Research, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • Center for Low-temperature Plasma Sciences, Nagoya University, Nagoya, Japan.

ORCID-Profile: Yashiro Motooka, Tatsuhiko Imaoka, Shinya Toyokuni

Förderung

  • Japan Society for the Promotion of Science
  • Core Research for Evolutional Science and Technology
  • Japan Science and Technology Agency

Zitieren

APA

Luo, Y., Akatsuka, S., Motooka, Y., Kong, Y., Zheng, H., Mashimo, T., Imaoka, T., & Toyokuni, S. (2023). BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile‐induced mesothelioma via ferroptosis resistance. Cancer Science, 114(4), 1423-1436. https://doi.org/10.1111/cas.15705

Vancouver

Luo Y, Akatsuka S, Motooka Y, Kong Y, Zheng H, Mashimo T, et al. BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile‐induced mesothelioma via ferroptosis resistance. Cancer Science. 2023;114(4):1423-1436. doi:10.1111/cas.15705

BibTeX
@article{Luo2023,
  author = {Luo, Yaguang and Akatsuka, Shinya and Motooka, Yashiro and Kong, Yingyi and Zheng, Hao and Mashimo, Tomoji and Imaoka, Tatsuhiko and Toyokuni, Shinya},
  title = {BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile‐induced mesothelioma via ferroptosis resistance},
  journal = {Cancer Science},
  year = {2023},
  volume = {114},
  number = {4},
  pages = {1423--1436},
  doi = {10.1111/cas.15705}
}
Kostenlos starten →